Partnership aims to expand early access to medicines

▤ Summary

Maprium and The Medicine Access Channel have formed a partnership to speed up early patient access to approved medicines that are not yet routinely reimbursed. The collaboration combines funding coordination with a technology platform that handles patient intake, ordering, tracking, and reporting. It focuses on Early Access Funding Agreements, which help bridge the gap between regulatory approval and standard reimbursement. The companies aim to reduce the administrative and financial barriers that can delay treatment access while keeping clinical decision-making and logistics independent.

▦ Linked Companies